Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ 0
Profit
Caution€ -6.6 million
▲ 8% vs 2024
Debts
High€ 25.5 million
▲ 4% vs 2024
EPIMEDE from Liège, company number BE0634750380, closed financial year 2025 with a result of € -6.6 million after tax. For that financial year EPIMEDE recorded a gross margin of € 0 and equity of € -6.4 million. Compared with financial year 2024, the result moved from € -7.2 million to € -6.6 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 11, 2025.
What happened at EPIMEDE?
What happened at EPIMEDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 6.6 million. Source: NBB ↗
- NOSHAQ PARTNERS SRL stepped down as director. NBB
- Albert CORHAY stepped down as director. NBB
- ETHIAS SA stepped down as director. NBB
- SFPI SA stepped down as director. NBB
- BNP PARIBAS FORTIS PRIVATE EQUITY MANAGEMENT SA stepped down as director. NBB
- MMLB MANAGEMENT SRL stepped down as director. NBB
- MONUMENT ASSURANCE BELGIUM SA stepped down as director. NBB
In short
From € 4.7 million profit in 2022 to € 6.6 million loss in 2025.
Paid € 2 in corporate taxes since 2022.
Best year ever: 2022, with € 4.7 million profit.
Pays suppliers within 100 days on average.
A new publication or filing at EPIMEDE? We notify you, reason included.
Follow EPIMEDENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 80% of HI TECH INVEST, 22.8% of WISHBONE, 16.5% of LASER ENGINEERING APPLICATIONS and 13.2% of ENDO TOOLS THERAPEUTICS itself.
Directors
According to the 2025 annual accounts
Director · represented by Eric BRANDT
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE +174 more
since 2020 · until 2025
Albert CORHAY
Director
since 2020 · until 2025
Director · represented by Effrosyni LEFKA
Also active at: ECETIA FINANCES, BEDRIJVENCENTRUM DE PUNT, DATASSUR +6 more
since 2020 · until 2025
Director · represented by François FONTAINE
Also active at: Aviapartner Belgium, Société Anonyme Belge de Constructions Aéronautiques, Société Nationale de Construction Aérospatiale +62 more
since 2020 · until 2025
BNP PARIBAS FORTIS PRIVATE EQUITY MANAGEMENT SA
Director · represented by Anne WAUTIER
since 2020 · until 2025
Chairman of the board · represented by Marc MOLES LE BAILLY
since 2020 · until 2025
Director · represented by Stéphanie WILMOTTE
Also active at: INTEGROWN INVEST, ANATIS
since 2021 · until 2025
Establishments
Establishment units
Physical locations of this company
Rue Lambert-Lombard 3
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 35 companies are registered at this address.
CAUTION MUTUELLE DES METIERS ET NEGOCES same network
SOGECOM same network
€ -151,456 gross margin · 2025
NOSHAQ
€ 9 million revenue · 2025
NOSHAQ IMMO
€ 2.6 million revenue · 2025
NOSHAQ VENTURE same network
€ 89,352 revenue · 2025
+30 more
Details
- Company number
- 0634.750.380
- VAT number
- BE 0634.750.380
- Registered office
- Rue Lambert-Lombard 3, 4000 Liège
- Names & denominations
- EPIMEDE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 July 2015
- Peppol
- Active · Active since 20 Nov 2020
- Contact
- info@epideme.com +3242216211